Biopharmaceutical Manufacturing, Upstream, Downstream processing news

Top Headlines

Merck to use prefabricated adjustable cleanrooms at $300m FLEx center

Reconfigurable cleanroom pods to be used at Merck’s formulation laboratory to address increasing demands of diverse patient populations.

Single-use bioprocessing set to grow by 14% through to 2024

The global single-use bioprocessing market is projected to grow to be worth $7bn by 2024, according to a recent report.

Merck’s CEO: ‘Huge risk’ taken in drug development requires return

Kenneth Frazier argues that the current market dynamics are bringing treatments to patients and the industry does not ‘have to apologise for that.’

Hired and Retired: The knock-on effect

BMS’ capture of Celgene caught much attention, due to the size and scale of the acqusition, but rival companies have taken the chance to snap up employees that have left after the deal.

GSK backs up genomics refocus with UCB partnership

GSK signs partnership deal with the University of California to advance genomic research, which sees the creation of a lab and funding for five years of research.